Veracyte Inc Forecast, price target & analysts
Veracyte Inc Target price 2025 - Analyst rating & recommendation
Veracyte Inc Classifications & Recommendation:
Veracyte Inc Price Target
| Target Price | $48.33 |
| Price | $33.84 |
| Potential |
42.83%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Veracyte Inc 2026 .
The average Veracyte Inc target price is $48.33.
This is
42.83%
register free of charge
$55.00
62.53%
register free of charge
$37.00
9.34%
register free of charge
|
|
| A rating was issued by 11 analysts: 9 Analysts recommend Veracyte Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Veracyte Inc stock has an average upside potential 2026 of
42.83%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 445.76 | 489.08 |
| 23.46% | 9.72% | |
| EBITDA Margin | 12.79% | 21.85% |
| 205.20% | 70.84% |
11 Analysts have issued a sales forecast Veracyte Inc 2025 . The average Veracyte Inc sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Veracyte Inc EBITDA forecast 2025. The average Veracyte Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.31 | 0.45 |
| 130.39% | 45.16% | |
| P/E | 74.92 | |
| EV/Sales | 4.87 |
6 Analysts have issued a Veracyte Inc forecast for earnings per share. The average Veracyte Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Veracyte Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current Veracyte Inc Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham | Locked ➜ Locked | Locked | Feb 25 2025 |
| Guggenheim | Locked ➜ Locked | Locked | Feb 25 2025 |
| UBS | Locked ➜ Locked | Locked | Feb 25 2025 |
| Needham | Locked ➜ Locked | Locked | Jan 29 2025 |
| Goldman Sachs | Locked ➜ Locked | Locked | Dec 05 2024 |
| Morgan Stanley | Locked ➜ Locked | Locked | Nov 18 2024 |
| Scotiabank | Locked ➜ Locked | Locked | Nov 08 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham: Locked ➜ Locked
|
Feb 25 2025 |
|
Locked
Guggenheim: Locked ➜ Locked
|
Feb 25 2025 |
|
Locked
UBS: Locked ➜ Locked
|
Feb 25 2025 |
|
Locked
Needham: Locked ➜ Locked
|
Jan 29 2025 |
|
Locked
Goldman Sachs: Locked ➜ Locked
|
Dec 05 2024 |
|
Locked
Morgan Stanley: Locked ➜ Locked
|
Nov 18 2024 |
|
Locked
Scotiabank: Locked ➜ Locked
|
Nov 08 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
